Founder(s)
Michael Malis, Steven Fitzsimmons
Sector
Health & PharmaTech
Stage Invested
Series B
Status
Current
No items found.
Related posts
View all
August 29, 2024
The business-in-a-box model: Grow Therapy’s playbook
We’ve earmarked $50M for the SignalFire AI Lab to provide the resources, capital, and credibility to help tomorrow’s AI leaders today.
Read more
July 30, 2024
The future of Health and PharmaTech: SignalFire’s perspective
We’ve earmarked $50M for the SignalFire AI Lab to provide the resources, capital, and credibility to help tomorrow’s AI leaders today.
Read more
July 17, 2024
Funding Freshpaint's $30M Series B for HIPAA-compliant healthcare marketing
We’ve earmarked $50M for the SignalFire AI Lab to provide the resources, capital, and credibility to help tomorrow’s AI leaders today.
Read more
*Portfolio company founders listed above have not received any compensation for this feedback and did not invest in a SignalFire fund. Please refer to our disclosures page for additional disclosures.